Natural killer cells and CD56+ T cells in the blood of multiple myeloma patients: Analysis by 4-colour flow cytometry

Communications in Clinical Cytometry

Volumn 26, Issue 2, 1996, Pages 121-124

  King, Malcolm A ^a   Radicchi Mastroianni, Monica A ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Multiple myeloma; NK cells; Non MHC restricted cytotoxic lymphocytes

Indexed keywords

CD56 ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; FLOW CYTOMETRY; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MULTIPLE MYELOMA; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD; ANTIGENS, CD56; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; MULTIPLE MYELOMA; T-LYMPHOCYTES;

EID: 0029949996     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19960615)26:2<121::AID-CYTO4>3.0.CO;2-J     Document Type: Article

References (17)

1. Whiteside TL, Herberman RB: The role of natural killer cells in human disease. Clin Immunol Immunopathol 53:1-23, 1989.
2. Whiteside TL, Herberman RB: Role of human natural killer cells in health and disease. Clin Diag Lab Immunol 1:125-133, 1994.
3. Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH: The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 136:4480-4486, 1986.
4. Nagler A, Lanier LL, Cwirla S, Phillips JH: Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 143:3183-3191, 1989.
5. - natural killer cells in vivo. J Exp Med 171:1527-1533, 1990.
6. Warren HS, Skipsey LJ: Phenotypic analysis of a resting subpopulation of human peripheral blood NK cells: The FcRγIII (CD16) molecule and NK cell differentiation. Immunology 72:150-157, 1991.
7. Warren HS, Kinnear BF, Skipsey LJ: Human natural killer (NK) cells: Requirements for cell proliferation and expansion of phenotypically novel subpopulations. Immunol Cell Biol 71:87-97, 1993.
8. Phillips JH, Le AM, Lanier LL: Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens. J Exp Med 159: 993-1008, 1984.
9. Lanier LL, Buck DW, Rhodes L, Ding A, Evans E, Barney C, Phillips J.H: Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J Exp Med 167:1572-1585, 1988.
10. LeFever AV, Funahashi A: Phenotype and function of natural killer cells in patients with bronchogenic carcinoma. Cancer Res 51: 5596-5601, 1991.
11. Einhorn S, Ahre A, Blomgren H, Johansson B, Mellstedt H, Strander H: Interferon and natural killer activity in multiple myeloma. Lack of correlation between interferon-induced enhancement of natural killer activity and clinical response to human interferon-a. Int J Cancer 30:167-172, 1982.
12. Osterborg A, Nilsson B, Bjorkholm M, Holm G, Mellstedt H: Natural killer cell activity in monoclonal gammopathies: Relation to disease activity. Eur J Haematol 45:153-157, 1990.
13. Gonzalez M, San Miguel JF, Gascon A, Moro MJ, Hernandez JM, Ortega F, Jimenez R, Guerras L, Romero M, Casanova F, Sanz MA, Portero JA, Orfao A: Increased expression of natural-killer-associated and activation antigens in multiple myeloma. Am J Hematol 39:84-89, 1992.
14. ++] and stimulation of protein kinase C. J Immunol 142:1854-1860, 1989.
15. + T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen). J Exp Med 162:2089-2106, 1985.
16. Loken MR, Brosnan JM, Bach BA, Ault KA: Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 11:453-459, 1990.
17. Uchida A, Yagita M, Sugiyama H, Hoshino T, Moore M: Strong natural killer (NK) cell activity in bone marrow of myeloma patients: accelerated maturation of bone marrow NK cells and their interaction with other bone marrow cells. Int J Cancer 34:375-381, 1984.